Augmentation of antitumor immunity by genetically engineered fibroblast cells to express both B7.1 and interleukin-7.
Kim, T.S., Chung, S.W., Hwang, S.Y.
Vaccine, 2000.06
102
Therapeutic antitumor response induced with epitope-pulsed fibroblasts gentically engineered for B7.1 expression and interferon-γ secretion.
Kim, T.S., Chung, S.W., Kim, S.H., Kang, S.N., Kang, B.Y., Hwang, S.Y., Lee, J.W.
Int. J. Cancer, 2000.08
103
Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of antigen-specific CTL and protection against tumor development in vivo.
Kim, T.S., Chung, S.W., Kim, S.H., Kang, B.Y., Hwang, S.Y., Lee, J.W.
Cancer Gene Therapy, 2000.06
104
Anti-allergic and anti-inflammatory triterpenes from medicinal herb Prunella vulgaris.
Ryu, S.Y., Oak, M.H., Yoon, S.K., Cho, D.I., Yoo, G.S., Kim, T.S., Kim, K.M.
Planta Medica, 2000.05
105
Induction of persistent resistance to Mycobacterium avium complex infection by IFN-γsecreting fibroblasts.
Kim, T.S., Chung, S.W., Kang, B.Y., Choe, Y.-K., Hwang, S.Y.
Vaccine, 2000.01
106
Inhibition of interleukin-12 (IL-12) production in lipopolysaccharide-activated macrophages by curcumin.
Kang, B.Y., Chung, S.W., Chung, W.-J., Im, S.-Y., Hwang, S.Y., Kim, T.S.
Eur. J. Pharmacol., 1999.11
107
Chloromethyl ketones inhibit interleukin-12 production in macrophages stimulated with lipopolysaccharide.
Kang, B.Y., Chung, S.W., Im, S.-Y., Hwang, S.Y., Kim, T.S.
Immunol. Lett., 1999.11
108
Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages.
Kang, B.Y., Song, Y.J., Kim, K.-M., Choe, Y.-K., Hwang, S.Y., Kim, T.S.
Br. J. Pharmacol., 1999.08
109
Sulfasalazine prevents Th1 immune response by suppressing IL-12 production in macrophages.
Kang, B.Y., Chung, S.W., Im, S.-Y., Choe, Y.K., Kim, T.S.
Immunology, 1999.08
110
IFN-γ and IL-4 targeted gene therapy for the atopic allergic disease.